As of April 19, 2025, Vigil Neuroscience (VIGL) has a market cap of $79.808 million USD. According to our data, Vigil Neuroscience is ranked No.7744 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $79.81 M |
14.84%
|
Dec 31, 2024 | $69.50 M |
-49.70%
|
Dec 29, 2023 | $0.14 B |
-72.96%
|
Dec 30, 2022 | $0.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Denali Therapeutics
DNLI
|
$1.85 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.70 B |
-0.000 M
|
![]() Netherlands
|
Market Cap | = | VIGL Stock Price | * | VIGL Shares Outstanding |
= | $1.71 | * | 46.67 M | |
= | $79.81 M |